购物车
- 全部删除
- 您的购物车当前为空
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) 是一种选择性蛋白激酶 C 抑制剂。它促进 Fas 介导的细胞凋亡,并抑制 T 细胞介导的自身免疫性疾病。
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) 是一种选择性蛋白激酶 C 抑制剂。它促进 Fas 介导的细胞凋亡,并抑制 T 细胞介导的自身免疫性疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 391 | 现货 | |
5 mg | ¥ 954 | 现货 | |
10 mg | ¥ 1,480 | 现货 | |
25 mg | ¥ 2,500 | 现货 | |
50 mg | ¥ 3,570 | 现货 | |
100 mg | ¥ 4,950 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,190 | 现货 |
产品描述 | Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) is a potent and selective PKC inhibitor (IC50: 158 nM for rat brain PKC). It has IC50s of 53, 195, 163, 213, and 175 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, PKC-ε, respectively. |
靶点活性 | PKCβ2:163 nM, PKC:158 nM(Rat Brain), PKCγ:213 nM, PKCα:53 nM, PKCε:175 nM, PKCβ1:195 nM |
体外活性 | Bisindolylmaleimide VIII acetate facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Bisindolylmaleimide VIII acetate (5 μM; 8, 12 hours) dramatically increases TRA-8-induced cell death in time-dependent and TRA-8 dose-dependent manners. Bisindolylmaleimide VIII acetate (5 μM; 6 hours) significantly decreases procaspase-8 at 4 h and completely disappears at 6 h after the combined treatment with TRA-8 [2]. |
体内活性 | Bisindolylmaleimide VIII acetate (100 μg; i.p.; every other day for three doses) results in nearly complete tumor regression combined toTRA-8. The alone treatment with Bisindolylmaleimide VIII acetate does not induce significant tumor regression [2]. |
别名 | Ro 31-7549 acetate, Bis VIII acetate |
分子量 | 458.51 |
分子式 | C26H26N4O4 |
CAS No. | 138516-31-1 |
Smiles | CC(O)=O.Cn1cc(C2=C(C(=O)NC2=O)c2cn(CCCN)c3ccccc23)c2ccccc12 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/ml (119.95 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容